Flecainide plus metoprolol vs metoprolol alone for rhythm control
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether adding flecainide to metoprolol can better reduce dangerous heart rhythm problems in people with mitral valve prolapse. It also checks safety and side effects compared with metoprolol alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and can sign consent.
- You have mitral valve prolapse confirmed by an echo or heart MRI (leaflets move at least 2 mm).
- You have ventricular rhythm problems on monitoring (such as frequent extra beats, ventricular tachycardia, or past aborted cardiac arrest).
- A doctor says you need anti-rhythm medicine because of your ventricular rhythm issues.
- If you can become pregnant, you must use effective birth control during the study and for 3 days after stopping study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart rhythm problems in people having mitral valve surgery to fix a leaky valve. It may help doctors better understand who is at risk for dangerous rhythms.
This trial tests whether the medication flecainide can reduce frequent extra heartbeats (called PVCs) that come from normal heart tissue, and may help prevent or reverse heart muscle problems caused by these extra beats.
This study tests if flecainide, a heart rhythm drug, is safe for people with both stable coronary artery disease and atrial fibrillation. It aims to help control irregular heartbeats without increasing risks.
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
This trial tests personalized medication strategies for people with Andersen-Tawil syndrome (ATS) or a specific type of heart condition called MEPPC. It aims to find the safest and most effective treatment for managing heart rhythm issues.
This trial compares two medicines—flecainide and amiodarone—to help restore normal rhythm during an emergency visit for paroxysmal atrial fibrillation (a-fib). It’s aimed at people who also have coronary artery disease but no ongoing (residual) heart ischemia, and who have enough heart pumping strength.
Hear when a new Mitral Valve Prolapse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.